Rising Treasury yields show how “enormously worried” the market is about inflation — and whether the Fed will back up its ...

Stocks close mostly higher as oil prices drop on pause in Iran war strikes and as traders await the Federal Reserve's interest-rate decision on Wednesday.

Vasant Dhar built one of the first AI-driven hedge funds. Here’s what he wants investors to know about the technology.

Inflation hit 3.5% last month, surpassing both the Fed’s 2% benchmark and the 10-year average of 3.18%, according to ...

Celestica raised its forecast for the year, citing expectations for stronger customer demand after sales jumped in its latest quarter.

SpaceX’s earnings report next week could unleash a further wave of selling, as some insiders will soon be able to unload ...

Prudential Financial's investment-management business arm has agreed to take full ownership of private credit and direct lending manager Deerpath Capital. Prudential on Monday said PGIM, which ...

Cognizant expanded its partnership with Anthropic to help more businesses integrate Claude models. The AI consulting and services company said Monday that the expansion is geared toward making AI ...

MapLight Therapeutics shares plunged to a 52-week low Monday morning after investors focused on mixed results from the company's Phase 2 schizophrenia trial, in which only one of two dosing regimens ...

Legend Biotech said that its chief executive officer, Ying Huang, has stepped down from the position after seven years at the company. The cell therapy company said Monday that it has appointed Alan ...

Amkor Technology logged an increase in sales and profit in the second quarter, as the company expanded partnerships and capitalized on the artificial intelligence momentum.

Shares of Legend Biotech fell after the cell-therapy company said its Chief Executive Ying Huang has resigned. The stock slipped 15% to $18.89 in recent trading, and is down more than 13% since the ...